| |
| |
|
| Insider
Information: |
Blin Emmanuel |
| Relationship: |
SVP, Chief Strategy Of... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,137 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$903,144 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,137 |
|
|
| Total
Value |
$903,144 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP, Chief Strategy Of... |
2017-03-10 |
20,137 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
474 |
14,071 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(379) |
15,551 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,275 |
23,690 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2017-03-10 |
4 |
D |
$58.32 |
$322,510 |
D/D |
(5,530) |
20,138 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2016-07-02 |
4 |
D |
$73.78 |
$16,158 |
D/D |
(219) |
12,297 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Chief Strategy Officer |
• – – |
2016-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
951 |
12,516 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-10 |
4 |
D |
$64.94 |
$186,573 |
D/D |
(2,873) |
11,565 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,707 |
13,498 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(22) |
5,424 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
789 |
4,284 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-06 |
4 |
D |
$64.71 |
$23,813 |
D/D |
(368) |
1,964 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
779 |
2,332 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2016-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
819 |
1,553 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2015-07-02 |
4 |
D |
$67.48 |
$14,778 |
D/D |
(219) |
734 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2015-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
951 |
953 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Commercialization |
• – – |
2015-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
